Back to search
Secondary Progressive Multiple Sclerosis (SPMS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Secondary Progressive Multiple Sclerosis (SPMS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Secondary Progressive Multiple Sclerosis (SPMS) trials you may qualify forThe purpose of this study is to provide efficacy and safety data for remibrutinib in patients with secondary progressive multiple sclerosis (SPMS)
The main objective of the study is to determine the recommended phase 2 dose (RP2D) of Azercabtagene zapreleucel (azer-cel).
The goal of this clinical trial is to treat male and female participants with two types of Multiple Sclerosis (MS) called primary progressive or secondary progr…
The goal of this clinical trial is to know if rituximab can improve cognitive and hand functions in secondary progressive multiple sclerosis (SPMS) patients wit…
This project is to: 1. Quantify differences in axonal integrity and organization in aMS versus naPMS patients. 2. Quantify changes in axonal integrity and orga…
To evaluate the efficacy and safety of oral masitinib versus placebo in the treatment of patients with primary progressive or secondary progressive multiple scl…
Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or fingolimod…